Dasatinib (Tasigna® and generic dasatinib) – Patient Information for Australia

Dasatinib is an oral medicine used to treat certain blood cancers, particularly some forms of chronic myeloid leukaemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukaemia (Ph+ ALL). This guide explains how dasatinib works, how it is used, key safety points, and practical tips for everyday life in Australia.

Basic product information

Dasatinib is a targeted cancer therapy taken as tablets. It works by blocking specific enzymes (tyrosine kinases) involved in abnormal signalling that drives the growth of certain cancer cells.

In Australia, dasatinib products are regulated medicines. Availability can depend on PBS status (if applicable for your situation), prescriber authority, and stock levels.

How dasatinib works (mechanism of action)

Dasatinib belongs to the group of medicines called tyrosine kinase inhibitors. It primarily inhibits BCR-ABL, a fusion protein found in many cases of CML and Ph+ ALL.

• Stops cancer signalling: BCR-ABL activity supports uncontrolled cell growth. Dasatinib blocks this activity.
• Helps reduce leukaemia cells: By interrupting survival and proliferation pathways, dasatinib helps control disease progression.
• Targets additional kinases: Dasatinib can also affect other signalling proteins (for example, Src family kinases), which contributes to both its benefits and some side-effect risks.

Pharmacokinetics (how the body handles dasatinib)

Understanding how dasatinib is absorbed and processed may help explain why food timing matters and how interactions can occur. Note: individual results vary.

• Absorption: Dasatinib absorption is influenced by gastric pH and food timing. Strict instructions about meals are commonly used to help ensure consistent drug exposure.
• Peak levels: The medicine reaches peak concentration after oral dosing (time to peak may vary).
• Distribution: Dasatinib is widely distributed in the body.
• Metabolism: It is metabolised mainly by liver enzymes (including CYP3A4).
• Elimination: Metabolites are cleared primarily via the faeces.

Typical use

Dasatinib is used to treat:

• Chronic myeloid leukaemia (CML): including treatment in chronic phase, and in some cases after prior therapy.
• Philadelphia chromosome–positive acute lymphoblastic leukaemia (Ph+ ALL): including in adult patients and other eligible groups depending on local guidance and regimen.

It is commonly used as part of a treatment plan monitored with blood tests and disease-response assessments (such as BCR-ABL monitoring) over time.

Indications (when it may be used)

Dasatinib is indicated for certain patients with:

• Ph+ chronic myeloid leukaemia (CML), including newly diagnosed and/or after earlier therapy (depending on regimen)
• Ph+ acute lymphoblastic leukaemia (Ph+ ALL), including in adult patients (depending on regimen)

Eligibility depends on the specific diagnosis, previous treatments, and laboratory findings. Your oncology team may also consider baseline risk factors and other medical conditions.

How to take dasatinib: timing and food interactions

Why food timing matters

Dasatinib exposure can increase with food. For many patients, instructions aim to reduce variability and help maintain consistent dosing effects. This is why meal timing instructions are typically strict.

General food timing guidance

Follow the exact directions provided with your medicine. As a general principle commonly used with dasatinib:

• Take it at the same time each day according to your regimen.
• Avoid taking with food unless your care team specifically advises otherwise.
• Maintain the recommended gap from meals: many regimens require taking tablets either at least about 2 hours after food and then waiting about 1 hour before eating again. Always follow the specific instructions for your product and regimen.
• Stay consistent with the meal pattern to reduce day-to-day fluctuations.

Acid-reducing medicines and gastric pH

Medicines that reduce stomach acid (for example, some proton pump inhibitors and H₂-blockers) can alter absorption. If you use any acid-reducing therapy, discuss it with your healthcare professional before starting or changing it.

Alcohol and medicine interactions

Alcohol

Moderate alcohol use may be tolerated by some people, but it can increase stress on the liver and worsen fatigue or nausea. Because dasatinib is metabolised in the liver and can affect blood counts, it’s safest to:

• Discuss alcohol intake with your doctor or pharmacist, especially if you have liver test abnormalities.
• Limit alcohol if you experience side effects such as nausea, dizziness, or tiredness.
• Avoid binge drinking, as it may increase risk of complications.

Important medicine interactions

Dasatinib is metabolised by enzymes including CYP3A4 and is also influenced by drug transporters. Interactions may increase side effects or reduce effectiveness.

• CYP3A4 inhibitors (can increase dasatinib levels): some antifungals (azoles), certain antibiotics (macrolides), and some antivirals may raise exposure.
• CYP3A4 inducers (can decrease dasatinib levels): some seizure medicines (antiepileptics), rifampicin-like antibiotics, and some herbal products can reduce exposure.
• Herbal supplements: St John’s wort can significantly change drug levels—avoid unless your pharmacist says it’s safe.
• Other medicines that affect the heart rhythm: Some drugs that prolong QT may add risk; discuss all medications.
• Blood thinners/anticoagulants: Dasatinib can increase bleeding risk in some situations and interactions are possible. Always seek advice before combining with anticoagulants or antiplatelets.

Keep a current list of all medicines and supplements (including “natural” products) and review it with your pharmacist or oncology team.

Dosing: typical approach and what to expect

The exact dose and schedule depend on:

• the diagnosis (CML vs Ph+ ALL),
• phase and risk category,
• age and treatment history,
• side effects and blood test results,
• drug interactions and tolerability.

Dosing regimens may be once or twice daily and may be adjusted during treatment. Dose changes are common in practice when managing adverse effects or laboratory abnormalities.

If you miss a dose

Missing a dose can reduce effectiveness. Practical guidance typically includes:

• Check your medicine instructions for the specific “missed dose” advice for your regimen.
• Do not double up unless told to do so.
• Contact your oncology team or pharmacist for tailored advice if you are unsure.

Stopping or changing dose

Do not stop or adjust dasatinib without clinical advice. If side effects occur, clinicians may manage them by:

• dose reduction,
• temporary interruption,
• supportive care (for example, anti-nausea treatment),
• additional monitoring.

Safety profile: common and serious side effects

Most people experience some side effects while taking dasatinib. Many are manageable, especially with early reporting. Seek medical help urgently for severe symptoms.

Common side effects

• Low blood counts (anaemia, neutropenia, thrombocytopenia), which can increase infection or bleeding risk
• Nausea, diarrhoea or constipation
• Fatigue, weakness, headache
• Skin rash, itching
• Muscle or bone pain
• Fluid-related symptoms such as swelling (may occur in some patients)
• Shortness of breath (can have multiple causes—report promptly)

Serious or important risks

• Pleural effusion (fluid around the lung): may present with new or worsening cough, chest tightness, or shortness of breath.
• Fluid retention and ascites (fluid in the abdomen): may cause rapid weight gain, abdominal swelling, or discomfort.
• Cardiac rhythm changes (QT prolongation): symptoms may include dizziness, palpitations, or fainting.
• Haemorrhage (bleeding): may be more likely if platelet counts are low or if combined with blood-thinning medicines.
• Infections due to low white blood cells: seek advice promptly for fever or signs of infection.
• Hepatotoxicity (liver enzyme elevations): monitored with liver function tests.

When to seek urgent medical help

Get urgent medical attention if you experience:

• trouble breathing, severe chest pain, or sudden worsening shortness of breath
• fainting, severe dizziness, or palpitations with feeling unwell
• signs of serious infection (for example, high fever, chills, rapidly worsening symptoms)
• uncontrolled bleeding or black/tarry stools, or vomiting blood
• severe allergic reaction symptoms (swelling of face/lips, hives, difficulty breathing)

Practical use tips (making treatment easier)

Set up a daily routine

• Choose a consistent time and plan around meal spacing.
• Use reminders (phone alarms) to reduce missed doses.
• Keep the medicine in a cool, dry place, away from moisture.

Manage nausea and fatigue early

• Discuss anti-nausea options if nausea occurs.
• Hydrate regularly and balance activity with rest.
• If fatigue affects daily function, tell your care team—adjustments may be possible.

Blood count monitoring

Regular blood tests are important. They help detect low blood counts early and guide dose adjustments. Attend scheduled tests and report symptoms such as fever, bruising, unusual tiredness, or bleeding.

Watch for breathing changes

Report new or worsening cough, shortness of breath, rapid weight gain, or swelling promptly. Early management can reduce complications.

Medication list and interaction checks

• Bring an up-to-date list of all medicines to appointments.
• Ask before starting new OTC products (including cold/flu remedies) and supplements.
• Be cautious with antacids or acid-suppressing medicines—timing and choice matter.

Alternative options

Treatment choices for CML and Ph+ ALL vary by patient factors, previous responses, and tolerability. Your oncology team may consider:

• Other BCR-ABL tyrosine kinase inhibitors (examples include imatinib, nilotinib, bosutinib, and others depending on availability and patient suitability)
• Combination strategies in specific Ph+ ALL scenarios
• Supportive care and monitoring approaches to manage symptoms and side effects

The best alternative depends on your disease status, prior therapy history, and risk of specific side effects (for example, fluid retention or cardiac concerns).

Market and legal context for Australia

In Australia, cancer medicines like dasatinib are regulated under the Therapeutic Goods framework. Access may occur through:

• hospital-based oncology services and specialist prescribing pathways,
• pharmacies that dispense authorised medicines under appropriate arrangements,
• PBS listings when criteria are met (eligibility varies by indication and patient circumstances).

Policies can change over time, and availability may depend on national supply, hospital formularies, and product brand vs generic substitution rules. If you’re unsure about access, a pharmacy can help explain what is required for dispensing in your situation.

Recent guidance and monitoring (high-level overview)

Clinical practice evolves as more data become available. In general, recent and ongoing guidance emphasises:

• Regular response monitoring for BCR-ABL (or equivalent markers) to confirm treatment effectiveness
• Close safety monitoring, including blood counts and assessment for pleural effusion/fluid retention
• Medication review to manage interactions (especially strong CYP3A4 inhibitors/inducers and acid-reducing therapies)
• Individualised dose adjustments based on tolerability and lab results

Always follow the most current instructions provided by your oncology team for your specific regimen.

Delivery and availability (Australia-focused)

Availability of dasatinib tablets can vary due to supply schedules, brand vs generic availability, and dispensing requirements. When ordering online in Australia, look for:

• Clear stock status and estimated dispatch times
• Accurate strength and formulation (for example, tablet strength must match your regimen)
• Secure packaging to protect tablets from moisture and damage
• Tracking information and reliable delivery options

For best continuity of care, order with enough lead time to avoid treatment interruptions. If you are close to running out, contact the pharmacy promptly.

FAQ

1) What is dasatinib used for?

Dasatinib is used to treat certain blood cancers, mainly Philadelphia chromosome–positive chronic myeloid leukaemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukaemia (Ph+ ALL), depending on the regimen and patient factors.

2) How should I take it with food?

Dasatinib is taken with strict meal timing in many regimens to avoid changes in absorption. Common guidance is to take it after a gap from food and to wait before eating again. Follow the exact meal instructions for your product and schedule.

3) Can I take dasatinib with antacids or acid reducers?

Some acid-reducing medicines can affect absorption. Ask your pharmacist before using proton pump inhibitors, H₂-blockers, or antacids, and follow any timing advice they provide.

4) What are the most important side effects to watch for?

Pay attention to shortness of breath, cough, chest discomfort, unusual swelling or rapid weight gain, fever or infection symptoms, bleeding/bruising, and signs of liver problems. Report new or severe symptoms promptly.

5) Is it safe to drink alcohol?

Alcohol may worsen fatigue and may increase stress on the liver. It’s best to discuss your alcohol intake with your clinician, particularly if you have liver test abnormalities.

6) What medicines can interact with dasatinib?

Many interactions are possible. Common categories include strong CYP3A4 inhibitors/inducers (certain antifungals, antibiotics, antivirals, seizure medicines), St John’s wort, and medicines that can affect heart rhythm. Always share your full medication list.

7) What should I do if I miss a dose?

Do not double up. Follow the missed-dose advice provided with your regimen, or contact your pharmacist/oncology team for guidance.

8) Will I need blood tests?

Yes. Regular blood counts and other monitoring (including liver tests and sometimes ECG or symptom checks) help ensure safe use and to guide dose adjustments.

9) Are there alternatives to dasatinib?

Other targeted therapies (including different tyrosine kinase inhibitors) may be considered depending on diagnosis, previous response, and side effect profile. Your oncology team can discuss suitable options.

10) How can I get my dasatinib delivered in Australia?

Availability depends on stock and dispensing arrangements. Choose reputable online pharmacy services that provide clear product strength, secure packaging, and realistic delivery timeframes. Consider ordering early to prevent treatment interruption.

Note: This information is general and may not cover every individual situation. Always follow the instructions from your healthcare professional and the product information provided with your tablets.